LNAI Lunai Bioworks Inc.
- Stocks
- Healthcare
- NASDAQ: LNAI
Price (delayed)
$1.17
Market cap
$27.12M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$10.8
Enterprise value
$37.2M
Relative Growth:
Rel. Growth:
1
Relative Strength:
Rel. Strength:
0
Relative Valuation:
Rel. Valuation:
N/A
Relative Profitability:
Rel. Profitability:
0
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B
Highlights
The debt has surged by 169% year-on-year and by 45% since the previous quarter
Lunai Bioworks's net income has plunged by 166% from the previous quarter and by 101% YoY
Key stats
What are the main financial stats of LNAI
Market
Valuations
Earnings
Shares outstanding
23.18M
Market cap
$27.12M
Enterprise value
$37.2M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
PEG
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$188.97M
Net income
-$178.01M
EBIT
-$177.28M
EBITDA
-$177.15M
Free cash flow
-$7.87M
Per share
Balance sheet
Liquidity
EPS
-$10.8
EPS diluted
-$10.8
Free cash flow per share
-$0.48
Book value per share
-$1.24
Revenue per share
$0
TBVPS
$0.14
Total assets
$8.23M
Total liabilities
$29.58M
Debt
$10.17M
Equity
-$21.35M
Working capital
-$28.11M
Debt to equity
-0.48
Current ratio
0.04
Quick ratio
0.02
Net debt/EBITDA
-0.06
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-198.3%
Return on equity
-288.1%
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LNAI stock price
How has the Lunai Bioworks stock price performed over time
Intraday
40.29%
1 week
21.88%
1 month
-9.3%
1 year
-80.3%
YTD
-86%
QTD
-7.87%
Financial performance
How have Lunai Bioworks's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$188.97M
Net income
-$178.01M
Gross margin
N/A
Net margin
N/A
Lunai Bioworks's net income has plunged by 166% from the previous quarter and by 101% YoY
LNAI's operating income has shrunk by 139% QoQ and by 131% YoY
Price vs fundamentals
How does LNAI's price correlate with its fundamentals
Growth
What is Lunai Bioworks's growth rate over time
Valuation
What is Lunai Bioworks stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS fell by 19% YoY
The equity has dropped by 124% since the previous quarter and by 116% year-on-year
Efficiency
How efficient is Lunai Bioworks business performance
LNAI's ROE has dropped by 190% year-on-year
The ROA has plunged by 156% YoY
Dividends
What is LNAI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LNAI.
Financial health
How did Lunai Bioworks financials performed over time
LNAI's total assets is 72% lower than its total liabilities
LNAI's total assets has shrunk by 95% YoY and by 93% QoQ
Lunai Bioworks's quick ratio has shrunk by 78% QoQ and by 50% YoY
The debt is 148% greater than the equity
The debt has surged by 169% year-on-year and by 45% since the previous quarter
The equity has dropped by 124% since the previous quarter and by 116% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.